As indicated in Fig. 6b, the number of AML patients with cytoplasmic PCNA localization was 19/26 (73.1%) versus 16/24 (66.7%) of patients among NK-AML and CBF-AML cohorts, respectively, suggesting that cytoplasmic PCNA localization was not dependent on the karyotype. Here, CEBPZ is linked to acute myeloid leukemia.